Chatterton & Associates
CVS icon

Chatterton & Associates’s CVS Health CVS Stock Holding History

Chatterton & Associates’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-2,134
Closed -$219K – 107
2026
Q2 		$219K Buy
+2,134
New +$190K 0.13% 98

Other funds holding CVS

Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return
Davis Selected Advisers
Davis Selected Advisers Tucson, Arizona $23.2B AUM 18.42% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Chatterton & Associates's CVS Position: Q3 2026 in Review

Chatterton & Associates sold out of CVS Health (CVS) in Q3 2026, closing a stake of 2,134 shares — an estimated $219K sold.

Chatterton & Associates first reported a position in CVS in Q2 2026 and held it in 1 quarter. The position peaked at $219K in Q2 2026. 1,475 funds tracked by Wall St. Rank hold CVS as of Q3 2026.

  • Chatterton & Associates reported no remaining CVS Health position as of Q3 2026 after selling out during the quarter.
  • Chatterton & Associates sold 2,134 CVS Health shares in Q3 2026, an estimated $219K.
  • Chatterton & Associates first reported a position in CVS Health in Q2 2026 and held it in 1 quarter.
  • Chatterton & Associates's CVS Health position peaked at $219K in Q2 2026.
  • 1,475 funds tracked by Wall St. Rank held CVS Health as of Q3 2026.

Based on Chatterton & Associates's 13F filing for Q3 2026, filed 12 Nov 2026.